HER2CLIMB FDA Approval
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=WU7diTKPeXM
A discussion on the FDA approval of tucatinib from the HER2CLIMB study, for managing patients with HER2-positive metastatic breast cancer (mBC). The key opinion leader also considers how this agent fits within the treatment paradigm. • For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
#############################
